Method and apparatus to control delivery of high-voltage and anti-tachy pacing therapy in an implantable medical device

• US 6,718,204 B2
• Filed: 07/30/2001
• Issued: 04/06/2004
• Est. Priority Date: 07/30/2001
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Sharma, Vinod, DeGroot, Paul J., Krause, Paul, Ousdigian, Kevin T., Padmanabhan, Vasant
• Primary Examiner(s): Jastrzab, Jeffrey R.
• Assistant Examiner(s): Oropeza, Frances P.
• Application Number:
  US09/918,224
• Publication Number:
  US 20030023273A1
• Time in Patent Office: 981 Days
• Field of Search: 600/373, 600/374, 600/509, 600/515, 600/518, 607/4, 607/5, 607/7, 607/9, 607/11, 607/14, 607/15
• US Class Current: 607/4
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/3688 configured for switching the pacing mode, e.g. from AAI to DDD
• CPC Class Codes: A61N 1/3925 Monitoring; Protecting
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
• CPC Class Codes: A61N 1/39622 Pacing therapy
• CPC Class Codes: A61N 1/3987 characterised by the timing or triggering of the shock

Abstract

A system and method for delivering both anti-tachy pacing (ATP) therapy and high-voltage shock therapy in response to detection of abnormal cardiac rhythms is disclosed. The system controls the time between delivering ATP therapy and the charging of high-voltage capacitors in preparation for shock delivery based on a predetermined set of criteria. In one embodiment, the inventive system operates in an ATP During Capacitor Charging (ATP-DCC) mode wherein all, or substantially all, of the ATP therapy is delivered during charging of the high-voltage capacitors. Based on evaluation of the predetermined set of criteria, the system may switch to an additional ATP Before Capacitor Charging (ATP-BCC) mode, wherein substantially all of the ATP therapy is delivered prior to charging of the high-voltage capacitor. According to one aspect of the invention, the predetermined set of criteria is based, at least in part, on the effectiveness of previously-delivered ATP therapy.

Claims

1. A system for use in controlling electrical therapy delivered to a heart, comprising:

a first circuit that is charged to deliver high-voltage electrical stimulation to the heart;

a second circuit to deliver anti-tachy pacing (ATP) therapy to the heart;

a control circuit coupled to the first and second circuits to adjust a time of charging of the first circuit relative to a time of delivering ATP therapy based on predetermined criteria;

means for operating in an ATP-DCC mode to initiate charging of the first circuit during delivery of the ATP therapy;

means for operating in an ATP-DCC mode to initiate charging of the first circuit after the delivery of the ATP therapy; and

means for transitioning between the ATP-BCC mode and the ATP-DCC mode based on predetermined criteria related to the effectiveness of the previously-delivered ATP therapy.

2. The system of claim 1, wherein the control circuit includes means for transitioning from the ATP-BCC mode to the ATP-DCC mode based on a first parameter indicating a number of failed ATP therapy delivery attempts while operating in ATP-BCC mode.

3. The system of claim 2, wherein the first parameter is measured as a number of failed ATP attempts out of a total number of ATP therapy attempts delivered.

4. The system of claim 2, wherein the control circuit includes means for transitioning from the ATP-DCC mode to the ATP-BCC mode based on a second parameter indicating a number of successful ATP therapy delivery attempts while operating in ATP-DCC mode.

5. The system of claim 4, and further including a storage device coupled to the control circuit to store the first and second parameters, and wherein at least one of the first and second parameters are programmable.

6. The system of claim 4, wherein the second parameter is measured as a number of successful ATP attempts out of a total number of ATP therapy attempts delivered.

7. The system of claim 4, and further including at least one electrode coupled to the control circuit to sense cardiac rhythms, and a processing circuit coupled to the control circuit to analyze types of the cardiac rhythms, and wherein the predetermined criteria takes into account the types of the cardiac rhythms occurring in the heart.

8. The system of claim 7, wherein the control circuit includes means for utilizing different values for the first and second parameters, each of the values being respectively associated with a type of cardiac rhythm occurring during delivery of the ATP therapy.

9. The system of claim 1, and further including a storage device coupled to the control circuit to store the predetermined criteria, and wherein the predetermined criteria is programmably selected to be specific to a given patient.

10. The system of claim 1, and further including at least one electrode coupled to the control circuit capable of detecting rhythms of the heart, and wherein the predetermined criteria is based on a length of one or more of the detected rhythms of the heart.

11. The system of claim 7, wherein the control circuit further includes means for adjusting the time of charging of the first circuit relative to the time of delivering ATP therapy based on a frequency of occurrence of one or more of the cardiac rhythms.

12. The system of claim 11, wherein the control circuit includes means for transitioning from the ATP-DCC mode to the ATP-BCC mode based on a detection of VT storms, wherein a predetermined number of VT rhythms are detected within a predetermined period of time.

13. The system of claim 7, wherein the predetermined criteria includes criteria associated with a change in a type of cardiac rhythm occurring prior to the delivery of the ATP therapy.

14. The system of claim 13, wherein the control circuit includes means for transitioning from the ATP-BCC mode to the ATP-DCC mode based on the criteria associated with a change in a type of cardiac rhythm occurring during the delivery of the ATP therapy.

15. The system of claim 1, wherein the second circuit delivers a second sequence of the ATP therapy during charging of the first circuit.

16. The system of claim 1, wherein the control circuit transitions between the ATP-BCC mode and the ATP-DCC mode in response to a length of an episode corresponding to the previously delivered ATP therapy.

28. The system of claim 10, wherein the control circuit determines whether an episode has terminated in response to delivery of the ATP therapy by the second circuit and delivery of the high voltage electrical stimulation by the first circuit is aborted in response to the episode terminating.

17. A method for use in delivering electrical stimulation to a heart, comprising the steps of:

a.) delivering anti-tachy pacing (ATP) therapy to a patient'"'"'s heart;

b.) charging a high-voltage capacitor in preparation to deliver high-voltage electrical stimulation to the heart; and

c.) controlling a time of performing step b.) in relation to a time of performing step a.) based on a predetermined set of criteria, wherein step c.) includes operating in a ATP-DCC mode wherein substantially all of step a.) is performed during step b.), and wherein step c.) includes switching from the ATP-DCC mode to a ATP-BCC mode wherein substantially all of step a.) is performed before step b.) is performed, the switching being based on the predetermined set of criteria.

18. The method of claim 17, wherein the predetermined set of criteria is programmable, and further including the step of programming the predetermined set of criteria.

19. The method of claim 17, and further including

monitoring effectiveness of the ATP therapy in terminating abnormal cardiac rhythms; and

wherein step c.) is performed based on the predetermined set of criteria, which takes into account the effectiveness of the ATP therapy in terminating abnormal cardiac rhythms.

20. The method of claim 19, wherein step c.) further includes switching from the ATP-BCC mode to the ATP-DCC mode based on the predetermined set of criteria.

21. The method of claim 20, wherein the switching from the ATP-BCC mode to the ATP-DCC mode occurs after unsuccessfully delivering ATP therapy a first predetermined number of times while in the ATP-BCC mode.

22. The method of claim 21, wherein the switching from the ATP-DCC mode to the ATP-BCC mode occurs after successfully delivering ATP therapy a second predetermined number of times while in the ATP-BCC mode.

23. The method of claim 17, and further including analyzing morphology of cardiac rhythms detected in the heart;

and wherein the predetermined set of criteria in step c.) is based on the morphology of cardiac rhythms detected in the heart.

24. The method of claim 23, wherein step c.) further includes switching from the ATP-DCC mode to the ATP-BCC mode based on a frequency of occurrence of predetermined ones of the cardiac rhythms detected in the heart.

25. The method of claim 24, wherein step c.) further includes switching from the ATP-DCC mode to the ATP-BCC mode based on detection of VT storms, wherein a predetermined number of ventricular tachycardia (VT) episodes are detected within a predetermined period of time.

26. The method of claim 23, wherein step c.) further includes switching from the ATP-BCC mode to the ATP-DCC mode based on a change in the morphology of the cardiac rhythms detected in the heart.

27. The method of claim 19, and further including discontinuing step a.) after unsuccessfully delivering ATP therapy a predetermined number of times.